Next-Generation Sequencing.

作者: Matthieu Le Gallo , Fred Lozy , Daphne W. Bell

DOI: 10.1007/978-3-319-43139-0_5

关键词:

摘要: Endometrial cancers are the most frequently diagnosed gynecological malignancy and were expected to be seventh leading cause of cancer death among American women in 2015. The majority endometrial serous or endometrioid histology. Most human tumors, including driven by acquisition pathogenic mutations genes. Thus, identification somatic within tumor genomes is an entry point toward gene discovery. However, efforts pinpoint have, until recently, relied on high-throughput sequencing single genes families using Sanger sequencing. Although this approach has been fruitful, cost throughput generally prohibits systematic ~22,000 that make up exome. recent development next-generation technologies changed paradigm providing capability rapidly sequence exomes, transcriptomes, at relatively low cost. Remarkably, application technology catalog mutational landscapes revealed, for first time, can classified into four distinct molecular subgroups. In chapter, we overview characteristic genomic features each subgroup discuss known putative have emerged from carcinomas.

参考文章(208)
Osamu Tanizawa, Naoki Terakawa, Alan O. Perantoni, Jerry M. Rice, Takayuki Enomoto, Masaki Inoue, K-ras Activation in Neoplasms of the Human Female Reproductive Tract Cancer Research. ,vol. 50, pp. 6139- 6145 ,(1990)
Bharati Bapat, Laurent Briollais, Vessela Vassileva, Anna Millar, William Chapman, Genes Involved in DNA Repair Are Mutational Targets in Endometrial Cancers with Microsatellite Instability Cancer Research. ,vol. 62, pp. 4095- 4099 ,(2002)
Shinji Higashi, Eizo Iseki, Michiko Minegishi, Takashi Togo, Tomohiro Kabuta, Keiji Wada, GIGYF2 is present in endosomal compartments in the mammalian brains and enhances IGF-1-induced ERK1/2 activation. Journal of Neurochemistry. ,vol. 115, pp. 423- 437 ,(2010) , 10.1111/J.1471-4159.2010.06930.X
Marian S. Blazes, Kathleen R. Cho, Steven I. Wang, Ramon Parsons, Shikha Bose, Lora Hedrick Ellenson, Hironori Tashiro, Jing Li, Rong Wu, Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Research. ,vol. 57, pp. 3935- 3940 ,(1997)
Robert J. Kurman, Christina Isacson, Kathleen R. Cho, Ross Levine, Hironori Tashiro, Lora Hedrick, p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis American Journal of Pathology. ,vol. 150, pp. 177- 185 ,(1997)
Andrew Berchuck, John I. Risinger, J. Carl Barrett, A. Kate Hayes, PTEN/MMAC1 Mutations in Endometrial Cancers Cancer Research. ,vol. 57, pp. 4736- 4738 ,(1997)
Murat Gokden, Laura Hutchins, Sergio Pecorelli, Juan J Roman, Martin J Cannon, Michela Palmieri, Alessandro D Santin, Donna Dunn, Timothy O'Brien, Groesbeck P Parham, Stefania Bellone, Jamshed Agha, Overexpression of HER-2/neu in uterine serous papillary cancer. Clinical Cancer Research. ,vol. 8, pp. 1271- 1279 ,(2002)
Andrew Berchuck, John I. Risinger, P. Andrew Futreal, Rex C. Bentley, G. Larry Maxwell, J. Carl Barrett, Heather Shaw, Curtis Gumbs, Mutation of the PTEN Tumor Suppressor Gene in Endometrial Hyperplasias Cancer Research. ,vol. 58, pp. 2500- 2503 ,(1998)
Setsuo Hirohashi, Takeshi Fukuchi, Shiro Nozawa, Michiie Sakamoto, Hitoshi Tsuda, Keiji Maruyama, β-Catenin Mutation in Carcinoma of the Uterine Endometrium Cancer Research. ,vol. 58, pp. 3526- 3528 ,(1998)
Caroline C. Billingsley, David E. Cohn, David G. Mutch, Julie A. Stephens, Adrian A. Suarez, Paul J. Goodfellow, Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing. Cancer. ,vol. 121, pp. 386- 394 ,(2015) , 10.1002/CNCR.29046